As above mentioned, men carrying germline mutations in DNA repair genes, such as BRCA1, BRCA2, CHECK2, and ATM, are at increased risk of developing prostate cancer and of prostate cancer-related mortality [145]. This evidence concerns the gene ATM and prostate cancer.